- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- Study from NCPA sheds new light on med synchronization programs
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
- Americans more likely than others to prefer generics, study finds
NEW YORK — Indian generic drug maker Lupin has launched an authorized generic version of a birth control pill made by Warner Chilcott, according to published reports.
Dow Jones reported that Lupin launched an authorized generic of Femcon (norethindrone and ethinyl estradiol tablets, ferrous fumarate tablets).
An authorized generic is a branded drug sold under its generic name at a reduced price, usually through a third-party company.